HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K S Nandakumar Selected Research

Experimental Arthritis

7/2011Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis.
1/2011Heterogeneous stock mice are susceptible to encephalomyelitis and antibody-initiated arthritis but not to collagen- and G6PI-induced arthritis.
1/2009The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders.
1/2009C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
4/2005Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
9/2001IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K S Nandakumar Research Topics

Disease

6Arthritis (Polyarthritis)
07/2011 - 09/2001
6Experimental Arthritis
07/2011 - 09/2001
3Encephalomyelitis (Myeloencephalitis)
01/2011 - 04/2005
3Rheumatoid Arthritis
01/2009 - 09/2001
2Inflammation (Inflammations)
10/2011 - 03/2011
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2009 - 04/2005
1Asthma (Bronchial Asthma)
10/2011
1Leukemia
10/2011
1Allergic Rhinitis
10/2011
1Osteoporosis
07/2011
1Autoimmune Diseases (Autoimmune Disease)
01/2009
1Multiple Sclerosis
04/2005
1Colitis
09/2001

Drug/Important Bio-Agent (IBA)

4CollagenIBA
07/2011 - 01/2009
2Collagen Type II (Type II Collagen)IBA
01/2011 - 09/2001
2AntibodiesIBA
01/2011 - 09/2001
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
10/2011
1BresolIBA
10/2011
1Raloxifene Hydrochloride (Evista)FDA Link
07/2011
1Estradiol (Delestrogen)FDA LinkGeneric
07/2011
1Selective Estrogen Receptor Modulators (SERM)IBA
07/2011
1septilinIBA
03/2011
1Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA
01/2011
1AntigensIBA
01/2011
1Proteins (Proteins, Gene)FDA Link
01/2011
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2011
1rabeximodIBA
01/2009
1Therapeutic UsesIBA
01/2009
1Complement C4b-Binding ProteinIBA
01/2009
1Complement Inactivating AgentsIBA
01/2009
1pristane (pristan)IBA
04/2005
1Methotrexate (Mexate)FDA LinkGeneric
04/2005
1CytokinesIBA
09/2001
1Anti-Bacterial Agents (Antibiotics)IBA
09/2001
1Interleukin-10 (Interleukin 10)IBA
09/2001